GAIL BOUDREAUX
CIK 1287920 · President and CEO · last filed 2026-07-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$147.20M
Companies
9
Total Filings
141
Lifetime Open-Market Net
-$36.02M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ELV | President and CEO | 169,991 | $385.73 | $65.57M | -$13.59M | 8 | 2026-07-17 |
| TGT | Director | 12,192 | $144.20 | $1.76M | $0 | 6 | 2026-03-13 |
| Elevance Health, Inc. (ANTM) Delisted | President and CEO | 94,041 | $482.58 | $45.38M | $2.00M | 6 | 2022-03-03 |
| ZBH | Director | 2,095 | $95.75 | $200.6K | $250.0K | 41 | 2021-04-02 |
| ANTX | President and CEO | 11,104 | $4.70 | $52.2K | $0 | 1 | 2018-03-05 |
| XEL | Director | 1,780 | $80.33 | $143.0K | $50.0K | 29 | 2018-01-02 |
| NVAX | Director | 10,000 | $7.37 | $73.7K | $144.8K | 4 | 2017-03-20 |
| UNH | EVP & CEO, UnitedHealthcare | 184,731 | $428.79 | $79.21M | -$24.88M | 39 | 2014-09-25 |
| GENZ | Director | 5,000 | $38.46 | $192.3K | $0 | 6 | 2011-04-06 |
Recent Filings · Page 3 of 15
141 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-10-02 | ZBH | Grant (A) | — | $0 | EDGAR |
| 2020-07-02 | ZBH | Grant (A) | — | $0 | EDGAR |
| 2020-05-12 | ZBH | Grant (A) | — | $0 | EDGAR |
| 2020-04-02 | ZBH | Grant (A) | — | $0 | EDGAR |
| 2020-03-04 | Elevance Health, Inc. (ANTM) Delisted | Mixed | +41,722 | -$661.9K | EDGAR |
| 2020-01-31 | Elevance Health, Inc. (ANTM) Delisted | Buy (P) | +7,600 | $2.00M | EDGAR |
| 2020-01-03 | ZBH | Grant (A) | — | $0 | EDGAR |
| 2019-10-02 | ZBH | Grant (A) | — | $0 | EDGAR |
| 2019-07-02 | ZBH | Grant (A) | — | $0 | EDGAR |
| 2019-05-14 | ZBH | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.